NCT05812573

Brief Summary

Retrospectively review the clinical characteristics of patients with multiple endocrine neoplasia type I in National Taiwan University Hospital.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
300

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Mar 2023

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 14, 2023

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

March 15, 2023

Completed
29 days until next milestone

First Posted

Study publicly available on registry

April 13, 2023

Completed
2 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 15, 2023

Completed
10 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 14, 2024

Completed
Last Updated

April 13, 2023

Status Verified

March 1, 2023

Enrollment Period

1 month

First QC Date

March 15, 2023

Last Update Submit

April 2, 2023

Conditions

Multiple Endocrine Neoplasia

Outcome Measures

Primary Outcomes (1)

  • Number or endocrine organs involved

    The number of endocrine organs involved in MEN patients

    2023/2/14-2033/2/14

Study Arms (1)

multiple endocrine neoplasia

patients with multiple endocrine neoplasia

Other: no intervention

Interventions

no interventionOTHER

No intervention, only observation

multiple endocrine neoplasia

Eligibility Criteria

Age18 Years - 99 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with multiple endocrine neoplasia who age 18 to 99 years old

You may qualify if:

  • Patients with multiple endocrine neoplasia

You may not qualify if:

  • Patients younger than 18 years old

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Taiwan University Hospital

Taipei, 100, Taiwan

RECRUITING

MeSH Terms

Conditions

Multiple Endocrine Neoplasia

Condition Hierarchy (Ancestors)

Endocrine Gland NeoplasmsNeoplasms by SiteNeoplasmsNeoplasms, Multiple PrimaryNeoplastic Syndromes, HereditaryGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesEndocrine System Diseases

Central Study Contacts

Shyang-Rong Shih, MD, PhD

CONTACT

+886-972653337srshih@ntu.edu.tw

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 15, 2023

First Posted

April 13, 2023

Study Start

March 14, 2023

Primary Completion

April 15, 2023

Study Completion

February 14, 2024

Last Updated

April 13, 2023

Record last verified: 2023-03

Locations

TW(1)